EP3137081
Búprenorfín tvíliða og notkun hennar við kvillum í meltingarvegi
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
27.4.2015EP published:
15.11.2017EP application number:
15720244.1
EP translation filed:
20.12.2017Grant published:
15.1.2018EPO information:
European Patent Register
Max expiry date:
26.4.2035Expiry date:
26.4.2025
Title:
BUPRENORPHINE DIMER AND ITS USE IN TREATMENT OF GASTROINTESTINAL DISORDERS
Timeline
Today
27.4.2015EP application
15.11.2017EP Publication
20.12.2017Translation submitted
15.1.2018Registration published
26.4.2025Expires
Owner
Name:
Orphomed, Inc.Address:
806 Denise Court, 94941, Mill Valley, CA, US
Inventor
Name:
SINGH, NikhileshAddress:
Mill Valley, California, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201461985207 PDate:
28.4.2014Country:
US
Number:
201562101768 PDate:
9.1.2015Country:
US
Number:
201562176883 PDate:
9.1.2015Country:
US
Classification
Categories:
A61K 31/485, A61P 25/04, C07D 489/00, C07C 233/16, A61K 31/137, A61K 31/167, C07D 489/12, C07D 519/00, C07D 489/02, C07D 489/08
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 27.3.2018
Expires: 26.4.2019
Payer: Árnason Faktor
Number: 5
Paid: 26.3.2019
Expires: 26.4.2020
Payer: Árnason Faktor
Number: 6
Paid: 26.3.2020
Expires: 26.4.2021
Payer: Árnason Faktor ehf.
Number: 7
Paid: 10.3.2021
Expires: 26.4.2022
Payer: Árnason Faktor ehf.
Number: 8
Paid: 10.3.2022
Expires: 26.4.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 8.3.2023
Expires: 26.4.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 7.3.2024
Expires: 26.4.2025
Payer: Árnason Faktor ehf.